Kidney Disease News and Research

RSS

New review highlights advances in diabetes research and treatment

A new paper surveying advances in diabetes pathogenesis and treatment explores the complex factors contributing to the onset and progression of the disease, suggesting that an understanding of these dynamics is key to developing targeted interventions to reduce the risk of developing diabetes and managing its complications.

25 Jul 2024

High-risk NSAID prescriptions cost NHS £31 million

Prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to people at high risk of harm from them is estimated to cost the NHS in England around £31 million and cause more than 6,000 lost years of good health over 10 years, finds a study published by The BMJ today.

24 Jul 2024

Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.

23 Jul 2024

Revolutionary ATP imaging technique sheds light on kidney cell energy production

The prevalence of kidney disease has been increasing in Japan, with it now affecting one in eight adults, but developing effective treatment remains a challenge.

23 Jul 2024

Saffron: A golden remedy for modern health challenges

Review highlights saffron's potential in preventing and treating various human diseases through its bioactive compounds. Clinical and preclinical studies confirm saffron's benefits in conditions like maculopathy, depression, neurodegenerative diseases, and cancer.

21 Jul 2024

Extreme weather associated with higher rates of missed primary care appointments

Temperature extremes, becoming increasingly frequent due to growing global climate change, are associated with higher rates of missed primary care appointments, according to a recently published study from Drexel University researchers in the American Journal of Preventive Medicine.

18 Jul 2024

Exploring the expanding horizons of GLP-1 therapies beyond diabetes and obesity

In a Perspective, Daniel Drucker highlights the growing body of evidence that hints at the potential of glucagon-like peptide-1 (GLP-1)-based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders.

18 Jul 2024

New four-year initiative targets cardiovascular-kidney-metabolic syndrome

About 1 in 3 U.S. adults have at least three risk factors for cardiovascular-kidney-metabolic (CKM) syndrome, a health disorder related to the strong connections among cardiovascular disease, kidney disease and metabolic disease (such as Type 2 diabetes and obesity).

18 Jul 2024

Heart of the Matter: Early Diagnosis and Intervention in Heart Failure with Prof. Martin Cowie & Dr. Lisa Anderson

The future of heart failure treatment with AstraZeneca's Prof. Martin Cowie and Heart Failure Specialist and Consultant Cardiologist at St George’s Hospital Dr. Lisa Anderson.

17 Jul 2024

Bowel movement frequency is linked to long-term health, study suggests

Everybody poops, but not every day. New research by the Institute for Systems Biology (ISB) suggests bowel movement frequency is linked to long-term health.

16 Jul 2024

Long-term, 30-year CVD risk may help inform therapy for stage 1 hypertension

A comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should be considered in addition to the short-term, 10-year risk to help inform when to begin medication therapy for stage 1 hypertension, or high blood pressure, according to new research published today in Hypertension, an American Heart Association journal.

15 Jul 2024

The effect of supplementation with cornelian cherry on different cardiometabolic outcomes

A recent meta-analysis in Nutrients examined recent studies on the cornelian cherry, Cornus mas L., for evidence of its cardiometabolic benefit.

11 Jul 2024

Four years non-diabetic status after impaired glucose tolerance diagnosis cuts cardiovascular risks

Maintaining non-diabetic status for at least four years after impaired glucose tolerance diagnosis significantly lowers the risk of cardiovascular complications and mortality.

10 Jul 2024

Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes.

8 Jul 2024

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully delivered the second preclinical candidate compound (PCC) in its collaboration with Fosun Pharma in June 2024, a potential innovative therapeutic using synthetic lethal strategy for the treatment of solid tumors.

5 Jul 2024

Decoding the significance of subnormal liver enzyme activity

Liver diseases are commonly diagnosed using serum enzyme assays, particularly for aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), and 5'-nucleotidase (5'-NT).

3 Jul 2024

Medically tailored meals show promise for reducing healthcare costs

According to new research looking at every U.S. state, programs that deliver medically tailored meals (MTMs) to people with diet-sensitive conditions such as diabetes and heart disease along with limitations in the ability to perform daily activities could lead to substantial savings in healthcare costs.

1 Jul 2024

Kidney Disease News and Research

New review highlights advances in diabetes research and treatment

High-risk NSAID prescriptions cost NHS £31 million

Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

Revolutionary ATP imaging technique sheds light on kidney cell energy production

Saffron: A golden remedy for modern health challenges

Extreme weather associated with higher rates of missed primary care appointments

Exploring the expanding horizons of GLP-1 therapies beyond diabetes and obesity

New four-year initiative targets cardiovascular-kidney-metabolic syndrome

Heart of the Matter: Early Diagnosis and Intervention in Heart Failure with Prof. Martin Cowie & Dr. Lisa Anderson

Bowel movement frequency is linked to long-term health, study suggests

Long-term, 30-year CVD risk may help inform therapy for stage 1 hypertension

The effect of supplementation with cornelian cherry on different cardiometabolic outcomes

Four years non-diabetic status after impaired glucose tolerance diagnosis cuts cardiovascular risks

Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

Decoding the significance of subnormal liver enzyme activity

Medically tailored meals show promise for reducing healthcare costs

Nordic chronic kidney disease diet enhances health-related quality of life

Global burden of heart failure: prevalence, incidence, and risk factors unveiled

Loss of salt, body fluid can stimulate kidney regeneration and repair in mice

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News